Epicoccum Allergy Shots: The Underrated Minor Mold with Real Allergenic Potency
Epicoccum nigrum is the most clinically significant minor mold: it has the only formally WHO/IUIS-registered allergen in its peer group (Epi p 1 serine protease), sensitization reaching 39% in highly atopic cohorts, and 82% co-sensitization with other fungi including Alternaria. Despite this potency, no species-specific SCIT RCT exists — clinical management extrapolates from Alternaria DBPC-RCT evidence (Kuna 2011, Tabar 2019).
Epicoccum nigrum Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to epicoccum nigrum — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of epicoccum nigrum allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of epicoccum nigrum immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of epicoccum nigrum extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for epicoccum nigrum allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing epicoccum nigrum extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription epicoccum nigrum immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat epicoccum nigrum allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Epicoccum nigrum?
The biology, taxonomy, and clinical fingerprint of Epicoccum nigrum — the foundation of how SCIT targets it.
Epicoccum nigrum colonies display distinctive bright yellow-orange pigmentation; its large multicellular conidia primarily deposit in the upper airways.
- Scientific name
- Epicoccum nigrum (syn. E. purpurascens)
- Family
- DidymellaceaePleosporales order
- Type
- Outdoor and post-harvest dematiaceous saprophyte
- Native to
- Ubiquitous worldwide; saprophyte on leaf surfaces, cereal crops, and soil in temperate through subtropical regions
- Allergen proteins
- Epi p 1 (33.5 kDa serine protease, WHO/IUIS registered, recognized by 100% of Epicoccum-allergic patients — Bisht 2004)Additional IgE-binding bands at 12, 26, 42, 43 kDa identified in immunoblotting (Bisht 2004)
- Particle size
- Large multicellular conidia 15-25 µm with bright orange-red colony pigmentation
- Avoidance difficulty
- Very difficult
How Epicoccum nigrum Allergy Presents
Symptoms by body system — useful for distinguishing Epicoccum nigrum sensitivity from overlapping allergies and infections.
Respiratory
- Allergic rhinitis during late-summer Epicoccum spore peaks
- Asthma exacerbations in sensitized patients on high-count outdoor days
- Wheezing and bronchospasm comparable in severity to Alternaria-triggered asthma
- Persistent cough during seasonal mold exposure
Ocular
- Allergic conjunctivitis during outdoor peak season
- Itchy, red, watery eyes on high-count late-summer afternoons
- Periorbital puffiness in sensitized individuals
Dermal
- Atopic dermatitis flares correlating with outdoor Epicoccum spore peaks
- Skin pruritus during high-count periods
- Hypersensitivity pneumonitis (HP) from intense exposure — rare but documented in pediatric cases (Yoshida 1989)
Systemic
- Fatigue from chronic mold exposure during late-summer peak
- Sleep disruption from poorly controlled rhinitis and asthma
- Reduced exercise tolerance in asthmatic patients during peak season
- Malaise correlating with high-spore outdoor days
Epicoccum is the one minor mold I do not want my colleagues to dismiss. When I see a strong Epicoccum positive alongside Alternaria, I treat it as confirmation that we are dealing with a genuine Pleosporales sensitization worth taking seriously — not just a panel-filler positive. The SCIT decision is still driven by Alternaria evidence, but the Epicoccum titer adds clinical weight to the case for immunotherapy.
When & Where Epicoccum nigrum Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: late summer through early autumn, paralleling Alternaria aerobiology in temperate Northern Hemisphere regions· Approximately 12-16 weeks of clinically meaningful outdoor spore loads; Dutch aerobiological data shows loads comparable to Alternaria during peak (van der Maarel-Wierink 2008)
US Exposure Map
8 high-intensity statesWhat Epicoccum nigrum Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Epicoccum nigrum shows 82% cross-reactivity with other fungi in sensitized patients (Bisht 2004), with maximum cross-reactivity with Alternaria alternata via shared 43, 26, and 17 kDa IgE-binding bands. It also cross-reacts with Curvularia and Cladosporium.
Shared 43, 26, 17 kDa IgE-binding bands; maximum cross-reactivity in the Bisht 2004 characterization study
Pleosporales family co-sensitization; frequent co-occurrence on positive panels
Is SCIT Right for Your Epicoccum nigrum Allergy?
Answer five questions to evaluate whether your Epicoccum sensitization — the most potent among minor molds — warrants Pleosporales SCIT consideration.
How severe are your late-summer outdoor mold allergy symptoms?
The Epicoccum nigrum SCIT Protocol
Epicoccum sensitization as part of a Pleosporales sensitization pattern is addressed via Alternaria-based SCIT — the only mold with established DBPC-RCT evidence. No Epicoccum-specific SCIT vial is used. Mold vials are kept separate from pollen extracts to prevent protease degradation.
Weekly escalating doses of non-standardized Alternaria extract, self-administered at home through Curex with a mandatory 30-minute self-observation period and a prescribed epinephrine auto-injector on hand; the first injection and every dose change are Zoom-supervised by the care team. Pre-injection peak flow check is recommended given the Pleosporales-asthma severity association.
Maintenance injections continue monthly or every 2-4 weeks once the target dose is reached. Clinical response and local reaction size guide dose adjustments by your allergist.
After 3-5 years of maintenance, lasting tolerance is evaluated. Epicoccum-sensitized patients with significant polysensitization may require extended courses.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Epicoccum nigrum SCIT
No published SCIT RCT has evaluated Epicoccum nigrum as the primary immunizing antigen. Evidence extrapolates from Alternaria DBPC-RCTs, supported by the strong cross-reactivity data between Epicoccum and Alternaria (Bisht 2004).
- Alternaria SCIT: Combined symptom-medication score reduction (year 3)63%Kuna et al., J Allergy Clin Immunol 2011, N=111 children, DBPC-RCT
- Alternaria SCIT: Clinical improvement after 1 year (purified native Alt a 1)40%Tabar et al., J Allergy Clin Immunol 2019, purified Alt a 1 DBPC-RCT
Despite Epicoccum having the most robust allergen characterization among minor molds (WHO/IUIS-registered Epi p 1 recognized by 100% of sensitized patients), no species-specific SCIT RCT has been published. Therapeutic decisions for confirmed Epicoccum/Pleosporales sensitization extrapolate from Alternaria DBPC-RCT evidence. A board-certified allergist should confirm primary Pleosporales sensitization via rAlt a 1 component testing before committing to SCIT.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Epicoccum nigrum SCIT Side Effects
Alternaria-based mold SCIT carries a standard side-effect profile with somewhat elevated local reaction rates relative to pollen extracts due to protease content.
Local reactions
4 documentedSystemic reactions
4 documentedMold SCIT requires epinephrine and a mandatory 30-minute post-injection observation period — with Curex, you self-observe at home with a prescribed epinephrine auto-injector, and the first injection and every dose change are Zoom-supervised by the care team. For patients with asthma (common in Epicoccum-sensitized individuals), pre-injection peak flow measurement is required.
SCIT vs Alternatives for Epicoccum nigrum
Patients with Epicoccum sensitization and significant Pleosporales mold allergy have four main options: Alternaria-based SCIT, SLIT drops, environmental controls, or daily pharmacotherapy.
| Criterion | SCIT (Alternaria-based)Best | SLIT drops | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | 63% combined score reduction (Kuna 2011) for Pleosporales sensitization | Alternaria SLIT shows improvement; mold mix SLIT lacks strong evidence | Partial — outdoor saprophyte avoidance is limited | Symptomatic relief only |
| 5-yr cost | $3,500-$8,000 over 5 years | $500-$2,000/yr | HEPA filters $100-$500/yr | $500-$2,000/yr ongoing |
| Duration | 3-5 years | 3-5 years | Ongoing | Ongoing daily use |
| Convenience | Weekly then monthly clinic visits | Daily at-home use | Lifestyle modifications needed | Daily pills/sprays |
| Safety | Systemic reactions <1%; 30-min obs required | Lower systemic reaction risk than SCIT | No injection risks | Drug side effects with long-term use |
| Lasting effect | Yes — tolerance may persist after treatment | Evidence less robust for molds vs. pollens | No lasting desensitization effect | No lasting effect |
SCIT (Alternaria-based)Best
SLIT drops
Avoidance
Medications
For confirmed Epicoccum/Pleosporales sensitization with significant symptoms, Alternaria-based SCIT offers the best evidence — and Curex delivers that disease-modifying SCIT as weekly at-home self-injections at $129/month, removing the weekly clinic trips while keeping allergist oversight via telehealth, a prescribed epinephrine auto-injector confirmed on hand, and Zoom-supervised dosing for the first injection and every dose change. Discuss candidacy with your allergist as part of a comprehensive treatment plan.
What Epicoccum nigrum SCIT Actually Costs
Curex at-home testing includes Epicoccum (m14) in extended mold panels, surfacing a sensitization pattern that limited office-based panels often miss. Most major insurers cover mold SCIT injections under standard allergy benefits when ordered by a board-certified allergist; verify your specific plan's allergy benefit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your epicoccum nigrum allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Epicoccum nigrum SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Epi p 1 is the WHO/IUIS-registered major allergen of Epicoccum nigrum — a 33.5 kDa serine protease recognized by 100% of Epicoccum-allergic patients' sera in the original characterization study by Bisht and colleagues (Allergy 2004). It is the only formally named allergen in the entire minor-mold cluster covered in this subgroup. The clinical significance of Epi p 1 is that it distinguishes genuine Epicoccum sensitization from cross-reactive false positives via pan-fungal proteins like enolase. When your sIgE to Epicoccum is driven by Epi p 1 reactivity, your allergist can have more confidence that the positive reflects real Epicoccum-specific allergy rather than a non-specific pan-fungal cross-reaction.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.